DALS Annual EBITDA
-$1.76 M
0.00%
31 December 2022
Summary:
As of February 5, 2025, DALS annual earnings before interest, taxes, depreciation & amortization is -$1.76 millionDALS EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DALS Quarterly EBITDA
-$411.90 K
-$25.10 K-6.49%
31 March 2023
Summary:
As of February 5, 2025, DALS quarterly earnings before interest, taxes, depreciation & amortization is -$411.90 thousand, with the most recent change of -$25.10 thousand (-6.49%) on March 31, 2023. Over the past year, it has dropped by -$78.50 thousand (-23.55%).DALS Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DALS TTM EBITDA
-$1.84 M
-$78.50 K-4.46%
31 March 2023
Summary:
As of February 5, 2025, DALS TTM earnings before interest, taxes, depreciation & amortization is -$1.84 million, with the most recent change of -$78.50 thousand (-4.46%) on March 31, 2023. Over the past year, it has dropped by -$909.30 thousand (-97.84%).DALS TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DALS EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -23.6% | -97.8% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
DALS EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | at high | +864.6% | +4206.1% |
DA32 Life Science Tech Acquisition EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$411.90 K(+6.5%) | -$1.84 M(+4.5%) |
| Dec 2022 | -$1.76 M | -$386.80 K(-9.6%) | -$1.76 M(+6.9%) |
| Sept 2022 | - | -$427.80 K(-30.1%) | -$1.65 M(+9.8%) |
| June 2022 | - | -$612.20 K(+83.6%) | -$1.50 M(+61.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$333.40 K(+22.3%) | -$929.40 K(+55.9%) |
| Dec 2021 | - | -$272.50 K(-3.0%) | -$596.00 K(+84.2%) |
| Sept 2021 | - | -$280.80 K(+557.6%) | -$323.50 K(+657.6%) |
| June 2021 | - | -$42.70 K | -$42.70 K |
FAQ
- What is DA32 Life Science Tech Acquisition annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for DA32 Life Science Tech Acquisition?
- What is DA32 Life Science Tech Acquisition quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for DA32 Life Science Tech Acquisition?
- What is DA32 Life Science Tech Acquisition quarterly EBITDA year-on-year change?
- What is DA32 Life Science Tech Acquisition TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for DA32 Life Science Tech Acquisition?
- What is DA32 Life Science Tech Acquisition TTM EBITDA year-on-year change?
What is DA32 Life Science Tech Acquisition annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of DALS is -$1.76 M
What is the all time high annual EBITDA for DA32 Life Science Tech Acquisition?
DA32 Life Science Tech Acquisition all-time high annual earnings before interest, taxes, depreciation & amortization is -$1.76 M
What is DA32 Life Science Tech Acquisition quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of DALS is -$411.90 K
What is the all time high quarterly EBITDA for DA32 Life Science Tech Acquisition?
DA32 Life Science Tech Acquisition all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$42.70 K
What is DA32 Life Science Tech Acquisition quarterly EBITDA year-on-year change?
Over the past year, DALS quarterly earnings before interest, taxes, depreciation & amortization has changed by -$78.50 K (-23.55%)
What is DA32 Life Science Tech Acquisition TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of DALS is -$1.84 M
What is the all time high TTM EBITDA for DA32 Life Science Tech Acquisition?
DA32 Life Science Tech Acquisition all-time high TTM earnings before interest, taxes, depreciation & amortization is -$42.70 K
What is DA32 Life Science Tech Acquisition TTM EBITDA year-on-year change?
Over the past year, DALS TTM earnings before interest, taxes, depreciation & amortization has changed by -$909.30 K (-97.84%)